Yes- SGLB- what a run in 2013! The sector of course got beat back to reality last year following all the hype in 2013, but should (eventually) come back when numbers improve over time.
For last few months my partner (Harris) and I have been focused on biotech and tech stocks and have a strong track record. We like what we see in SLTD, (especially after spending time last week talking to management). We haven't had a loser yet and our picks have averaged > 70% gains in 2-3 months.